October 1, 2014 / 12:37 PM / 3 years ago

BRIEF-Innate Pharma announces Phase I trial of lirilumab in combination with elotuzumab

Oct 1 (Reuters) - Innate Pharma SA :

* Initiates Phase I clinical trial of lirilumab in combination with elotuzumab

* Phase I trial will test safety and tolerability of lirilumab in combination with elotuzumab in patients with multiple myeloma

* New Phase I initiated by Bristol-Myers Squibb is first combination trial of lirilumab in a hematological tumor type Source text for Eikon: Further company coverage: (Gdynia Newsroom: +48 58 698 39 20; Gdynia.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below